Kumar Santosh, Haque Mainul, Shetty Arvind, Choudhary Sumesh, Bhatt Rohan, Sinha Vivek, Manohar Balaji, Chowdhury Kona, Nusrat Nadia, Jahan Nasim, Kurdi Amanj, Ul Mustafa Zia, C Meyer Johanna, Sefah Israel A, Abdullah Adnan, Abdulrahman Jairoun Ammar, Godman Brian
Periodontology and Implantology, Karnavati University, Gandhinagar, IND.
Pharmacology and Therapeutics, National Defence University of Malaysia, Kuala Lumpur, MYS.
Cureus. 2022 Jul 25;14(7):e27230. doi: 10.7759/cureus.27230. eCollection 2022 Jul.
There is a growing focus on researching the management of children with COVID-19 admitted to hospital, especially among developing countries with new variants alongside concerns with the overuse of antibiotics. Patient care can be improved with guidelines, but concerns with the continued imprudent prescribing of antimicrobials, including antibiotics, antivirals, and antimalarials.
Consequently, a need to document the current management of children with COVID-19 across India. Key outcome measures included the percentage of prescribed antimicrobials, adherence to current guidelines, and mortality.
A point prevalence study using specially developed report forms among 30 hospitals in India.
The majority of admitted children were aged between 11 and 18 years (70%) and boys (65.8%). Reasons for admission included respiratory distress, breathing difficulties, and prolonged fever. 75.3% were prescribed antibiotics typically empirically (68.3% overall), with most on the Watch list (76.7%). There were no differences in antibiotic prescribing whether hospitals followed guidelines or not. There was also appreciable prescribing of antimalarials (21.4% of children), antivirals (15.2%), and antiparasitic medicines (27.2%) despite limited evidence. The majority of children (92.2%) made a full recovery.
It was encouraging to see low hospitalization rates. However, concerns about high empiric use of antibiotics and high use of antimalarials, antivirals, and antiparasitic medicines exist. These can be addressed by instigating appropriate stewardship programs.
对于收治新冠肺炎儿童患者的管理研究日益受到关注,尤其是在出现新变种的发展中国家,同时人们也担心抗生素的过度使用。指南有助于改善患者护理,但对于包括抗生素、抗病毒药物和抗疟药物在内的抗菌药物持续不谨慎处方的情况仍令人担忧。
因此,有必要记录印度各地新冠肺炎儿童患者的当前管理情况。关键结果指标包括抗菌药物处方比例、对现行指南的遵循情况以及死亡率。
在印度的30家医院使用专门设计的报告表进行了一项现况研究。
大多数入院儿童年龄在11至18岁之间(70%),且以男孩为主(65.8%)。入院原因包括呼吸窘迫、呼吸困难和持续发热。75.3%的儿童通常根据经验使用抗生素(总体为68.3%),大多数在观察名单上(76.7%)。无论医院是否遵循指南,抗生素处方情况均无差异。尽管证据有限,但抗疟药物(21.4%的儿童)、抗病毒药物(15.2%)和抗寄生虫药物(27.2%)的处方量也相当可观。大多数儿童(92.2%)完全康复。
住院率较低令人鼓舞。然而,对抗生素经验性高使用率以及抗疟药物、抗病毒药物和抗寄生虫药物的高使用率仍存在担忧。可通过实施适当的管理计划来解决这些问题。